The narrowing gap between gross margin (22.6%) and operating margin (-3.8%) in 2026Q2 implies that operating leverage is improving on the expense side, driven by the halving of R&D spend noted in prior income statement work, yet gross profit of roughly $1.1M still cannot cover the overhead base. Net margin of -3.5% looks benign next to the -180.3% printed in 2026Q1, but that comparison flatters the latest quarter; adjusting for the outsized non-operating charge embedded in 2026Q1, the underlying earning power appears consistently negative rather than recovering. Investors should treat operating margin, not net margin, as the cleaner read of run-rate performance given the volatility in below-the-line items.

ROIC of -9.8% against ROE of -9.2% in 2026Q2 shows the shortfall is not leverage-driven — with debt-to-equity near 0.04, the negative spread originates almost entirely in operating returns, meaning capital deployed into the business is generating losses at both the asset and equity level. Notably, ROIC has drifted more negative (-6.2% in 2025Q3 to -9.8% in 2026Q2) even as ROA held nearer -7.3%, a divergence that suggests the modest revenue recovery is not yet translating into returns on the invested base. The driver appears to be margin erosion rather than asset efficiency, since asset turnover of 0.02 leaves almost no volume through which improving margins could lift returns.

The progression from a negative CCC of -115 days in 2025Q2 to +188 days in 2026Q2 implies a sharp reversal in supplier financing advantage: payables days fell from 186 to 134 while receivables nearly doubled from 82 to 143, pointing to weaker bargaining position on both ends. Days inventory outstanding of 178, the highest in the series, is difficult to interpret against a revenue base of about $5.1M, so the turnover-driven signal should be treated cautiously rather than as evidence of stocking for demand. What is more actionable is that DSO of 143 days against quarterly revenue means a meaningful share of reported sales remains uncollected, which may help explain why operating cash losses have run smaller than reported net losses.

A current ratio of 6.52 alongside a quick ratio of 6.22 indicates virtually no inventory dependence in the liquidity stack — the gap between the two is only 0.30 — so near-term solvency rests on cash and receivables rather than unsold goods. The roughly 72% compression in the current ratio over ten quarters appears driven by a quadrupling of total liabilities to $49.2M against shrinking equity, not by a liquidity crisis, and cash rebuilding to $64.1M from an $11.8M trough provides meaningful runway relative to the ~$14.4M of quarterly FCF burn. Under severe stress, however, the cushion is only as good as the receivable book: with DSO at 143 days, a customer payment delay would tighten liquidity faster than the headline current ratio suggests, and the absence of disclosed interest coverage leaves debt service capacity unquantified.

A price-to-sales multiple of 12.47 is difficult to benchmark against QuantumScape or Solid Power on earnings grounds since all three post negative P/E multiples, but SES AI's 1.24x book value sits above Solid Power's 0.90x and well above Microvast's 0.42x, suggesting the market is paying a premium for what remains of the equity base. That premium looks harder to justify as book value erodes: equity has fallen from $347.4M to $187.1M as the accumulated deficit reached -$401.9M, so the P/B anchor is a moving and declining target rather than a stable floor. The negative P/E carries no analytical signal here, and with EV/EBITDA, forward P/E and P/FCF all unavailable, price-to-sales against the 43.8% revenue growth rate is arguably the only multiple investors can currently stress-test.